Christian Carrie, MD, and Celestia S. Higano, MD, on Results of the GETUG-AFU 16 Trial on Prostate Cancer 
    		2015 ASCO Annual Meeting
    	
    	
    	
    
        Christian Carrie, MD, of Centre Léon Bérard, and Celestia S. Higano, MD, of the University of Washington, discuss short hormonal therapy and radiotherapy as salvage treatment for relapse after radical prostatectomy (Abstract 5006).
    
    
    
    
       
       
    		Gregory T. Armstrong, MD, MSCE
		
		
        
		
		
		
		Gregory T. Armstrong, MD, MSCE, of St. Jude Children's Research Hospital, discusses the findings of a landmark survivorship study (Abstract LBA2).
			
			
     	
    
       
       
    		Charles F. von Gunten, MD, PhD
		
		
        
		
		
		
		Charles F. von Gunten, MD, PhD, of OhioHealth Kobacker House discusses the ROMANA 1 and 2 trials on cachexia in NSCLC and a study on olanzapine vs fosaprepitant for the prevention of nausea and vomiting (Abstracts 9500 and 9502).
			
			
     	
    
       
       
    		John Smyth, MD
		
		
        
		
		
		
		John Smyth, MD, of the University of Edinburgh, discusses oncology from an international point of view.
			
			
     	
    
       
       
    		Jame Abraham, MD
		
		
        
		
		
		
		Jame Abraham, MD, of the Cleveland Clinic discusses analyses of two trials for locally advanced, inflammatory, or early HER2-positive breast cancer using docetaxel, trastuzumab, pertuzumab, and neratinib (Abstracts 505 and 508).
			
			
     	
    
       
       
    		Andrew James Martin, PhD, and Anthony J. Olszanski, RPh, MD
		
		
        
		
		
		
		Andrew James Martin, PhD, of NHMRC Clinical Trials Centre, University of Sydney, and Anthony J. Olszanski, RPh, MD, of Fox Chase Cancer Center, discuss a form of vitamin B3 that reduced the incidence of new nonmelanoma skin cancers in high-risk patients (Abstract 9000).